封面
市場調查報告書
商品編碼
1878175

全球骨骼與關節健康補充品市場-2025-2030年預測

Global Bone And Joint Health Supplements Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 135 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球骨骼和關節健康補充劑市場預計將從 2025 年的 120.66 億美元成長到 2030 年的 171.94 億美元,複合年成長率為 7.34%。

骨骼為身體器官提供結構支撐和保護,關節則使身體能夠移動。維持骨骼和關節健康對整體健康至關重要,而鈣是維持骨骼完整性的關鍵營養素。骨骼和關節保健品含有必需的維生素和礦物質,有助於維持骨骼密度、改善關節活動範圍、緩解關節疼痛,並延緩骨關節炎等疾病的進展。這些產品為支持骨骼系統提供了一種便捷的方式,尤其能夠解決因老齡化導致的骨骼密度自然流失而引起的營養缺乏問題,而骨密度流失最初通常表現為關節不適。由於人口結構變化和消費者健康意識的提高,這類保健品市場需求顯著成長。

主要市場促進因素

骨骼和關節保健品市場的擴張主要受全球人口老化趨勢以及消費者對營養缺乏症認知提高的推動。

全球人口老化是推動該市場需求的最重要因素。老年人族群尤其容易患上損害骨骼和關節健康的疾病,例如骨質疏鬆症和類風濕性關節炎。自然老齡化過程會導致骨骼密度下降和關節軟骨磨損,增加骨折、疼痛和活動受限的發生率。老年人群體尋求保持積極獨立生活方式的解決方案,這為保健品生產商創造了一個龐大且不斷成長的目標市場。對關節舒適度和活動能力的追求是強大的消費動力,促使消費者願意為能夠針對這些與老齡化的健康問題提供特定支援的產品支付更高的價格。

除了人口結構壓力外,健康意識的廣泛提升也推動了市場成長。消費者越來越了解營養與長期健康之間的聯繫,尤其是某些微量營養素缺乏在骨骼和關節疾病發展中所扮演的角色。這種意識促使人們採取積極主動的健康管理方式,越來越多的人開始服用膳食補充劑作為預防措施。許多地區中產階級的壯大和可支配收入的增加,使得人們能夠更多地用於健康促進和預防性保健產品。此外,年輕人積極參與體育運動和健身活動,服用這些補充劑來支持關節功能和緩解運動壓力,進一步推動了這一趨勢,並將消費群體擴展到老年人以外的人群。

區域市場展望

預計北美將佔據全球骨骼和關節保健品市場的主要佔有率。該地區的領先地位源於多方面因素的共同作用:龐大且不斷成長的老齡人口、關節炎等關節疾病的高發生率,以及成熟的健康養生消費文化。人們對預防性醫療保健重要性的深刻認知以及長期服用膳食補充劑的習慣,共同促成了成熟且接受度高的市場的形成。高發生率的關節炎診斷率和人群中普遍存在的微量營養素缺乏症,持續推動對骨骼和關節健康解決方案的需求。

然而,預計亞太地區在預測期內將實現最快成長。這項加速成長受多種因素驅動,包括普遍存在的營養不良、人們健康意識的迅速提高,以及骨質疏鬆症和維生素D缺乏症等疾病的日益普遍。該地區的經濟發展是主要驅動力,可支配收入的增加使消費者能夠更多地購買高階保健產品,包括專業營養補充劑。龐大的人口基數、不斷成長的都市化以及現代健康理念的普及,為亞太地區帶來了巨大的成長潛力。亞太地區營養補充品公司的策略性企業發展和行銷舉措,正進一步加速其市場滲透和擴張。

本報告的主要優勢:

  • 深入分析:提供對主要和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局:了解全球主要參與者的策略舉措,並了解透過正確的策略實現市場滲透的潛力。
  • 市場促進因素與未來趨勢:探索市場促進因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議:利用洞察力,做出策略決策,在動態環境中發展新的業務流和收入來源。
  • 受眾廣泛:適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業,且經濟實惠。

您打算如何使用這份報告?

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍:

  • 2022年至2024年的歷史數據和2025年至2030年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區分類的收入成長和預測評估,包括國家/地區
  • 公司概況(策略、產品、財務資訊、關鍵發展等)

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 全球骨骼和關節健康補充品市場(按類型分類)

  • 介紹
  • 葡萄糖胺
  • 軟骨素
  • Omega-3脂肪酸
  • 維生素和礦物質補充劑
  • 其他

6. 全球骨骼和關節健康補充品市場(按配方分類)

  • 介紹
  • 膠囊和片劑
  • 粉末
  • 液體和軟膠囊
  • 其他

7. 全球骨骼和關節健康補充品市場(按分銷管道分類)

  • 介紹
  • 線上
  • 離線
    • 超級市場/大賣場
    • 藥局
    • 其他

8. 全球骨骼和關節健康補充品市場(按最終用戶分類)

  • 介紹
  • 運動員和健身愛好者
  • 老年人
  • 其他

9. 全球骨骼和關節健康補充品市場(按地區分類)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 台灣
    • 其他

第10章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第11章 公司簡介

  • Nestle SA
  • Procter & Gamble Company
  • Amway Corp
  • BASF SE
  • Glanbia plc
  • Herbalife Nutrition Ltd.
  • Pfizer Inc.
  • Archer Daniels Midland Company
  • Abbott Laboratories
  • Now Foods

第12章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061614517

The global bone and joint health supplements market, with a 7.34% CAGR, is anticipated to reach USD 17.194 billion in 2030 from USD 12.066 billion in 2025.

Bones provide the foundational structure and protection for the body's organs, while joints facilitate movement. Maintaining their health is critical for overall physical well-being, with calcium being a primary nutrient for bone integrity. Bone and joint health supplements are formulated to deliver essential vitamins and minerals that support bone density, enhance joint mobility, alleviate joint pain, and slow the progression of conditions like osteoarthritis. These products offer a convenient method to address nutritional gaps and support the skeletal system, particularly as natural bone density declines with age, often manifesting initially as joint discomfort. The market for these supplements is experiencing significant demand, driven by demographic shifts and evolving consumer health awareness.

Primary Market Drivers

The expansion of the bone and joint health supplements market is predominantly fueled by the global demographic transition towards an older population and a concurrent rise in consumer awareness regarding nutritional deficiencies.

The ageing global population represents the most substantial demand-side driver for this market. Older adults are disproportionately affected by conditions that degrade bone and joint health, including osteoporosis and rheumatoid arthritis. The natural ageing process leads to a decline in bone density and the wear-and-tear of joint cartilage, increasing the prevalence of fractures, pain, and reduced mobility. This demographic seeks solutions to maintain an active and independent lifestyle, creating a large and growing target market for supplement manufacturers. The focus on achieving joint comfort and ease of movement is a powerful consumer motivator, leading to a willingness to pay a premium for products that offer targeted support for these age-related concerns.

Alongside demographic pressures, a widespread increase in health consciousness is propelling market growth. Consumers are becoming more knowledgeable about the link between nutrition and long-term health, including the role that specific micronutrient deficiencies play in the development of bone and joint disorders. This awareness is driving a proactive approach to health management, where individuals are increasingly turning to dietary supplements as a preventative measure. The growth of the middle class in many regions, accompanied by rising disposable incomes, enables higher spending on wellness and preventive healthcare products. This trend is amplified by the participation of younger demographics in sports and fitness activities, who use these supplements to support joint function and recovery from physical stress, further broadening the consumer base beyond just the elderly.

Geographical Market Outlook

North America is projected to be the prominent shareholder in the global bone and joint health supplements market. The region's dominance is underpinned by a combination of a large and growing elderly population, a high prevalence of joint-related conditions such as arthritis, and a well-established consumer culture oriented toward health and wellness. High levels of awareness regarding the importance of preventative healthcare and a history of dietary supplement usage contribute to a mature and receptive market. The significant incidence of diagnosed arthritis and micronutrient deficiencies within the population creates a sustained demand for bone and joint health solutions.

The Asia Pacific region, however, is anticipated to be the fastest-growing market during the forecast period. This accelerated growth is driven by several factors, including widespread dietary deficiencies, rapidly increasing awareness of health and well-being, and a rising incidence of conditions like osteoporosis and vitamin D insufficiency. Economic development across the region is a key enabler, as rising disposable incomes allow consumers to spend more on premium health products, including specialized supplements. The large population base, combined with growing urbanization and the adoption of modern health trends, presents immense growth potential. Strategic business initiatives and marketing efforts by supplement companies within the APAC region are further catalyzing market penetration and expansion.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

  • GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY TYPE
  • Glucosamine
  • Chondroitin
  • Omega-3 Fatty Acid
  • Vitman & Mineral Supplement
  • Others
  • GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY FORMULATION
  • Capsules & Tablets
  • Powders
  • Liquids & Soft-Gel
  • Others
  • GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY DISTRIBUTION CHANNEL
  • Online
  • Offline
  • Supermarket/ Hypermarket
  • Pharmacies
  • Others
  • GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY END-USER
  • Athletes & Fitness Enthusiasts
  • Old-Age
  • Others
  • GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Glucosamine
  • 5.3. Chondroitin
  • 5.4. Omega-3 Fatty Acid
  • 5.5. Vitman & Mineral Supplement
  • 5.6. Others

6. GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY FORMULATION

  • 6.1. Introduction
  • 6.2. Capsules & Tablets
  • 6.3. Powders
  • 6.4. Liquids & Soft-Gel
  • 6.5. Others

7. GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY DISTRIBUTION CHANNELS

  • 7.1. Introduction
  • 7.2. Online
  • 7.3. Offline
    • 7.3.1. Supermarket/ Hypermarket
    • 7.3.2. Pharmacies
    • 7.3.3. Others

8. GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Athletes & Fitness Enthusiasts
  • 8.3. Old-Age
  • 8.4. Others

9. GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Nestle S.A
  • 11.2. Procter & Gamble Company
  • 11.3. Amway Corp
  • 11.4. BASF SE
  • 11.5. Glanbia plc
  • 11.6. Herbalife Nutrition Ltd.
  • 11.7. Pfizer Inc.
  • 11.8. Archer Daniels Midland Company
  • 11.9. Abbott Laboratories
  • 11.10. Now Foods

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations